• About us
  • Core Technology
  • Bio-Service
  • Investors
  • Careers
中文 English
  • About us
    • Introduction
    • Information
      • Announcement
      • Events
    • Management Team
      • Members
      • Consultants
    • Contact us
  • Core Technology
    • New medicine development platform
      • Skin diseases
      • metabolic diseases
      • Anti-inflammation
      • Diseases related to deficient mitochondrion
      • Others
  • Bio-Service
    • Scientific products
      • Western Blot
      • Cell Culture Supplement
      • Protein Isolation
      • Protein Quantification
      • Dyes and Buffer
    • Supplier
      • Lumiprobe
      • Rigaku Reagents
    • Service
      • Quantitative MS and systematic biological analysis experiment service
      • Protein identity certification experiment service
      • Microarray and biological information analysis experiment service
  • Investors
  • Careers

About us

  • >
  • About us
  • >
  • Information
  • >
  • Announcement
  • Introduction
  • Information
    • Announcement
    • Events
    • Corporate image
  • Management
    • Members
    • Consultants
  • Contact us
2020-06-24
The Singapore patent “Compounds for activating AMPK and the uses thereof.” is granted.

The Singapore patent Office has granted the No.11201602268X patent to its invention which titled "Compounds for activating AMPK and the uses thereof."

back
  • +886-2-26270835
  • +886-2-26270836
  • 6F.-3, No.21, Ln.583, Ruiguang Rd., Neihu Dist., Taipei 11492, Taiwan (R.O.C.)
Copyright © 2017 ENERGENESIS BIOMEDICAL CO., LTD. All Rights Reserved. Design by choice